Frequency Therapeutics is a biotechnology company that develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. The company enables disease modification through the transitory activation of these progenitor cells without the complexity of genetic engineering. The company's lead program re-creates sensory cells in the inner ear to treat chronic noise-induced hearing loss.